Laserfiche WebLink
WAC 388-877B-0405 <br /> Substance use disorder opiate substitution treatment services—Certification. <br /> An agency providing opiate substitution treatment services must be certified by the department's <br /> division of behavioral health and recovery to provide these services.An agency applying to provide <br /> opiate substitution treatment service must: <br /> (1)Submit to the department documentation that the agency has communicated with the county <br /> legislative authority and if applicable,the city legislative authority or tribal authority, in order to secure a <br /> location for the new opiate substitution treatment program that meets county,tribal or city land use <br /> ordinances. <br /> (2) Ensure that a community relations plan developed and completed in consultation with the <br /> county, city, or tribal authority or their designee, in order to minimize the impact of the opiate <br /> substitution treatment programs upon the business and residential neighborhoods in which the <br /> program is located.The plan must include: <br /> (a)Documentation of the strategies used to: <br /> (i)Obtain stakeholder input regarding the proposed location; <br /> (ii)Address any concerns identified by stakeholders;and <br /> (iii) Develop an ongoing community relations plan to address new concerns expressed by <br /> stakeholders. <br /> (b) Documentation that transportation systems will provide reasonable opportunities to persons in <br /> need of treatment to access the services of the program. <br /> (c)A copy of the application for: <br /> (i)A registration certificate from the Washington state board of pharmacy. <br /> (ii) Licensure to the federal Drug Enforcement Administration. <br /> (iii)Certification to the federal Center for Substance Abuse Treatment(CSAT)of the Substance <br /> Abuse and Mental Health Services Administration (SAMHSA). <br /> (iv)Accreditation from a federal CSAT/SAMHSA-approved opioid treatment program accreditation <br /> body. <br /> (d)A declaration to limit the number of individual program participants to three hundred fifty as <br /> specified in RCW 70.96A.410(1)(e). <br /> (e) For new applicants who operate opiate substitution treatment programs in another state, copies <br /> of all survey reports written by their national accreditation body and state certification, if applicable, <br /> within the past six years. <br /> (3) Have concurrent approval to provide opiate substitution treatment by: <br /> (a)The Washington State department of health board of pharmacy; <br /> 5 <br />